Vol 12, No 4 (April 28, 2023): Translational Lung Cancer Research

Original Article

False positivity in break apart fluorescence in-situ hybridization due to polyploidy
Anna Lena van Gulik, Ellen Sluydts, Liesbet Vervoort, Mark Kockx, Pim Kortman, Bauke Ylstra, Stephen P. Finn, Lukas Bubendorf, Idris Bahce, Daoud Sie, Teodora Radonic, Birgit Lissenberg-Witte, Erik Thunnissen
Efficacy of different therapies for brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
Mo Chen, Lingyun Wei, Qin Wang, Jingyuan Xie, Ke Xu, Tangfeng Lv, Yong Song, Ping Zhan
Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets
Midori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Gyotoku, Daisuke Sasaki, Norihito Kaku, Chikako Senju, Hiroaki Senju, Erika Imamura, Shinnosuke Takemoto, Kazuko Yamamoto, Noriho Sakamoto, Yasushi Obase, Tomoshi Tsuchiya, Minoru Fukuda, Hiroshi Soda, Kazuto Ashizawa, Junya Fukuoka, Takeshi Nagayasu, Katsunori Yanagihara, Hiroshi Mukae
Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot study
Tomonori Makiguchi, Hisashi Tanaka, Koichi Okudera, Kageaki Taima, Sadatomo Tasaka
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts
Arik Bernard Schulze, Daniela Vanessa Wenge, Georg Evers, Birthe Heitkötter, Annalen Bleckmann, Lars Henning Schmidt, Michael Mohr, Wolfgang Hartmann, Maria Francisca Arteaga, Jan-Henrik Mikesch
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
Jun Ma, Sze Huey Tan, Daniel Xing Cheng Yin, Nguyen Tuan Anh Tran, Gek San Tan, Gillianne Geet Yi Lai, Mei-Kim Ang, Ravindran Kanesvaran, Amit Jain, Tanujaa Rajasekaran, Eng-Huat Tan, Tony Kiat Hon Lim, Daniel Shao-Weng Tan, Darren Wan-Teck Lim, Quan Sing Ng, Wan Ling Tan
Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA
Xiaodong Ling, Luquan Zhang, Chengyuan Fang, Hao Liang, Jinhong Zhu, Jianqun Ma
Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p
Fei Ming, Binfeng Li, Shengzhong Yi, Guoliang Pi
Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101)
Rong Wang, Meiqi Shi, Mei Ji, Zhengxiang Han, Lingxiang Chen, Yong Liu, Kaihua Lu, Lianke Liu, Bi Chen, Xizhi Zhang, Liyun Miao, Yongqian Shu
Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis
Mai Zhang, Qian Huang, Min Yu, Jianxin Xue, Meijuan Huang, You Lu, Yan Zhang
Establishing a predictive model for tumor mutation burden status based on CT radiomics and clinical features of non-small cell lung cancer patients
Jihua Yang, Wenjia Shi, Zhen Yang, Hang Yu, Miaoyu Wang, Yuanhui Wei, Juyi Wen, Wei Zheng, Peng Zhang, Wei Zhao, Liang’an Chen

Review Article

Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
Mark G. Kris, Tetsuya Mitsudomi, Solange Peters
Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review
Catherine B. Meador, Zofia Piotrowska
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
Jeong Uk Lim, Eunyoung Lee, Sang-Yun Lee, Hyeong Jun Cho, Dong Hyuck Ahn, Yongki Hwang, Joon Young Choi, Chang Dong Yeo, Chan Kwon Park, Seung Joon Kim
Significance of circulating tumor cells in lung cancer: a narrative review
Gerhard Hamilton, Barbara Rath, Sandra Stickler
Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative review
Jiayan Chen, Chunwei Xu, Jiawen Lv, Wanjun Lu, Yixue Zhang, Dong Wang, Yong Song
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome
Hely Shah, Terry L. Ng